Category: Biotechnology
Biotechnology market research reports by Roots Analysis
-
CAR T-Cell Therapy Market by Target Antigens (CD19, BCMA, CD20, CD19/22, and Other Target Antigens), Target Indication (Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Large B-cell Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, and Others), Key Geographies (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World), Sales Forecast of Drugs and Leading Players: Industry Trends and Global Forecasts, Till 2035
CAR T-Cell Therapy Market by Target Antigens (CD19, BCMA, CD20, CD19/22, and Other Target Antigens), Target Indication (Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Large B-cell Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, and Others), Key Geographies (North ... Read More
-
Gene Therapy Market by Therapeutic Area (Cardiovascular Disorders, Dermatological Disorders, Genetic Disorders, Hematological Disorders, Metabolic Disorders, Muscle Disorders, Oncological Disorders, Ophthalmic Disorders and Other Disorders), Type of Vector (Adeno-associated Virus Vectors, Adenovirus Vectors, Herpes Simplex Virus Vectors, Lentivirus Vectors, Non-viral Vectors, Retrovirus Vectors and Other Viral Vectors), Type of Therapy (Gene Augmentation, Gene Editing, Gene Regulation, Oncolytic Immunotherapies and Other Therapies), Type of Gene Delivery Method (Ex Vivo Gene Delivery and In vivo Gene Delivery), Route of Administration (Intramuscular Route, Intratumoral Route, Intravenous Route, Subretinal Route and Other Routes of Administration), Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Rest of the World), Leading Players and Sales Forecast: Industry Trends and Global Forecasts, Till 2035
Gene Therapy Market by Therapeutic Area (Cardiovascular Disorders, Dermatological Disorders, Genetic Disorders, Hematological Disorders, Metabolic Disorders, Muscle Disorders, Oncological Disorders, Ophthalmic Disorders and Other Disorders), Type of Vector (Adeno-associated Virus Vectors, Adenovirus ... Read More
-
Cell Therapy Media Market by Type of Product (Culture Media, Kits, Cell Culture Reagents and Extracellular Matrices), Type of Cell Therapy (T-Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy and NK Cell Therapy), Scale of Operation (Clinical and Commercial), Type of End User (Industry and Non-Industry) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, Till 2035
Cell Therapy Media Market by Type of Product (Culture Media, Kits, Cell Culture Reagents and Extracellular Matrices), Type of Cell Therapy (T-Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy and NK Cell Therapy), Scale of Operation (Clinical and Commercial), Type of End User (Industry and Non ... Read More
-
Oligonucleotide Synthesis Market by Application Area (Research and Diagnostics, and Therapeutics), Type of Product Synthesized (Active Pharmaceutical Ingredients and Finished Dosage Forms), Type of Oligonucleotide Synthesized (Antisense, DNA, siRNA and Other Oligonucleotides), Scale of Operation (Clinical and Commercial), Therapeutic Area (Cardiovascular Disorders, Genetic Disorders, Liver Disorders, Rare Diseases, and Other Disorders), End-Users (Pharmaceutical / Biopharmaceutical Companies, Academic and Research Institutes, and Hospitals), Company Size (Small, Mid-sized, and Large and Very Large) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Oligonucleotide Synthesis Market by Application Area (Research and Diagnostics, and Therapeutics), Type of Product Synthesized (Active Pharmaceutical Ingredients and Finished Dosage Forms), Type of Oligonucleotide Synthesized (Antisense, DNA, siRNA and Other Oligonucleotides), Scale of Operation (Cl ... Read More
-
ADC Technology Market (Focus on ADC Linker & ADC Conjugation Technologies) by Generation of Technology (Third-Generation, Second-Generation and Next-Generation), Type of Conjugation (Chemical, Chemoenzymatic and Chemical), Type of Linker (Cleavable and Non-Cleavable), Type of Payment Model Adopted (Upfront Payments and Milestone Payments) and Key Geographical Regions (North America, Europe, and Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
ADC Technology Market (Focus on ADC Linker & ADC Conjugation Technologies) by Generation of Technology (Third-Generation, Second-Generation and Next-Generation), Type of Conjugation (Chemical, Chemoenzymatic and Chemical), Type of Linker (Cleavable and Non-Cleavable), Type of Payment Model Adopted ( ... Read More
-
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry and Non-Industry), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America (US, Canada and Mexico), Europe (Austria, France, Germany, Italy, Spain, Switzerland, UK and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Iran, Israel and Other Countries)): Industry Trends and Gl
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / ... Read More
-
mRNA Synthesis and Manufacturing Market by Type of Product (Drug Substances (APIs) and Drug Products (FDFs)), Application Area (mRNA-based Vaccines and mRNA-based Therapeutics), Therapeutic Area (Infectious Diseases, Oncological Disorders and Other Disorders) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
mRNA Synthesis and Manufacturing Market by Type of Product (Drug Substances (APIs) and Drug Products (FDFs)), Application Area (mRNA-based Vaccines and mRNA-based Therapeutics), Therapeutic Area (Infectious Diseases, Oncological Disorders and Other Disorders) and Key Geographical Regions (North Amer ... Read More
-
Cell Therapy Manufacturing Market by Type of Cell Therapy (T Cell Therapies, NK Cell Therapies, Dendritic Cell Therapies, and Stem Cell Therapies), Source of Cells (Autologous, Allogeneic and Unspecified), Scale of Operation (Clinical and Commercial), Type of Manufacturer (In-house Manufacturers and Contract Manufacturing Organizations) and Geography (North America, Europe, Asia Pacific, and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Cell Therapy Manufacturing Market by Type of Cell Therapy (T Cell Therapies, NK Cell Therapies, Dendritic Cell Therapies, and Stem Cell Therapies), Source of Cells (Autologous, Allogeneic and Unspecified), Scale of Operation (Clinical and Commercial), Type of Manufacturer (In-house Manufacturers and ... Read More
-
AI in Clinical Trials Market by Trial Phase (Phase I, Phase II and Phase III), Target Therapeutic Area (Cardiovascular Disorders, CNS Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-User (Pharmaceutical and Biotechnology Companies, and Other End-Users) and Key Geographical Regions (Asia-Pacific, Europe, Latin America, Middle East and North Africa, and North America): Industry Trends and Global Forecasts, Till 2035
AI in Clinical Trials Market by Trial Phase (Phase I, Phase II and Phase III), Target Therapeutic Area (Cardiovascular Disorders, CNS Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-User (Pharmaceutical and Biotechnology Companies, and Other End-U ... Read More
-
Biologics Contract Manufacturing Market by Type of Service(s) Offered (API, FDF), Type of Biologic Manufactured (Antibodies, Cell Therapies, Vaccines and Other Biologics), Type of Expression System Used (Mammalian, Microbial and Others), Scale of Operation (Preclinical / Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and MENA): Industry Trends and Global Forecasts, Till 2035
Biologics Contract Manufacturing Market by Type of Service(s) Offered (API, FDF), Type of Biologic Manufactured (Antibodies, Cell Therapies, Vaccines and Other Biologics), Type of Expression System Used (Mammalian, Microbial and Others), Scale of Operation (Preclinical / Clinical and Commercial), Co ... Read More
-
Aseptic Filling Machine Market by Type of Compatible Primary Container (Vials, Syringes, Cartridges, Ampoules, Capsules, and Other Containers), Scale of Operation (Clinical and Commercial), System Throughput (Low, Medium and High), End-user (Pharma / Biotech Companies and Contract Manufacturing Organizations) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Aseptic Filling Machine Market by Type of Compatible Primary Container (Vials, Syringes, Cartridges, Ampoules, Capsules, and Other Containers), Scale of Operation (Clinical and Commercial), System Throughput (Low, Medium and High), End-user (Pharma / Biotech Companies and Contract Manufacturing Orga ... Read More
-
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and Other Payloads), Target Antigens (HER-2 (ERBB2), CD79b, Trop-2, BCMA (TNFRSF17 / BCM), CD19, CD22, Tissue Factor, CD30, CEACAM5, Nectin 4 and Others) And Key Geographical Regions (North America (US, Canada), Europe (Germany, UK, France, Italy, Spain), and Asia-Pacific (China, Australia, Japan)): Industry Trends and Global Forecasts, Till 2035
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Link ... Read More
-
ADC Contract Manufacturing Market by Stage of Development (Phase I, Phase II, Phase III and Commercial), Process Component (Antibody, HPAPI / Cytotoxic Payload, Conjugation / Linker and Fill / Finish), Target Indication (Solid Tumors, Hematological Tumors and Others), Antibody Generation (Second, Third, Fourth and Next), Antibody Origin (Humanized, Chimeric, Murine and Others), Antibody Isotype (IgG1, IgG4 and Others), Type of Payload (Auristatin, Camptothecin, DNA Topoisomerase I Inhibitor, Maytansinoid and Others), Type of Linker (Maleimide, SMCC, Tetrapeptide-based linker, Valine-citrulline and Others), and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
ADC Contract Manufacturing Market by Stage of Development (Phase I, Phase II, Phase III and Commercial), Process Component (Antibody, HPAPI / Cytotoxic Payload, Conjugation / Linker and Fill / Finish), Target Indication (Solid Tumors, Hematological Tumors and Others), Antibody Generation (Second, Th ... Read More
-
Antibody Discovery Market by Type of Service Offered (Antigen Designing, Hit Generation, Lead Selection, Lead Optimization and Lead Characterization), Antibody Discovery Method (Hybridoma based, Library based, Single Cell based and Transgenic Animal based), Type of Antibody Generated (Monoclonal Antibodies, Bispecific Antibodies and Others), Nature of Antibody Generated (Chimeric, Human, Humanized and Murine), Type of Therapeutic Areas (Cardiovascular Disorders, Immunological Disorders, Infectious Disorders, Neurological Disorders, Oncological Disorders and Others) and Key Geographies (North America, Europe, Asia, Latin America, Middle East and North Africa and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Antibody Discovery Market by Type of Service Offered (Antigen Designing, Hit Generation, Lead Selection, Lead Optimization and Lead Characterization), Antibody Discovery Method (Hybridoma based, Library based, Single Cell based and Transgenic Animal based), Type of Antibody Generated (Monoclonal Ant ... Read More
-
mRNA Vaccine and Therapeutics Market (3rd Edition): Industry Trends and Global Forecasts, till 2035
mRNA Vaccine and Therapeutics Market (3rd Edition): Industry Trends and Global Forecasts, till 2035 The mRNA Vaccine and Therapeutics Market is valued at USD 9 billion in 2024 growing at a CAGR of 16% during the forecast period 2026-2035. Messenger ribonucleic acid (mRNA) is a form of single-strande ... Read More
-
Protein Expression Market: Industry Trends and Global Forecasts, Till 2035
Protein Expression Market: Industry Trends and Global Forecasts, Till 2035 The Protein Expression Market is valued at USD 2.7 billion in 2024 growing at a CAGR of 8% during the forecast period 2024-2035. Proteins, composed of long chains of amino acids, have become increasingly important in the deve ... Read More
-
Molecular Diagnostics Market
Molecular Diagnostics Market The Molecular Diagnostics Market is valued at USD 15.9 billion in 2024 growing at a CAGR of 6.2% during the forecast period 2024-2035. Molecular diagnostic tests are designed to detect specific sequences in human genomic samples, such as DNA or RNA, to diagnose specific ... Read More
-
3D Bioprinting Market: Industry Trends and Global Forecasts, Till 2035
3D Bioprinting Market: Industry Trends and Global Forecasts, Till 2035 The 3D Bioprinting Market is valued at USD 4 billion in 2024 growing at a CAGR of 17.2% during the forecast period 2024-2035. 3D bioprinting is the process of combining living cells, growth factors, bioinks, and biomaterials usin ... Read More
-
Cell Therapy Manufacturing Market (6th Edition): Industry Trends and Global Forecasts, Till 2035
Cell Therapy Manufacturing Market (6th Edition): Industry Trends and Global Forecasts, Till 2035 The cell therapy manufacturing market is valued at USD 4.90 billion in 2024 growing at a CAGR of 9.90% during the forecast period 2024-2035. Currently, over 300 cell therapies are in various stages of cl ... Read More
-
Gene Therapy Market (6th Edition): Industry Trends and Global Forecasts, Till 2035
Gene Therapy Market (6th Edition): Industry Trends and Global Forecasts, Till 2035 The Global Gene Therapy Market is valued at USD 2.4 billion in 2024 growing at a CAGR of 19.25% during the forecast period 2024-2035. A diverse range of disorders arising from congenital abnormalities and inherited ge ... Read More
-
Proteomics Market: Industry Trends and Global Forecasts, till 2035
Proteomics Market: Industry Trends and Global Forecasts, till 2035 Proteomics Market: Industry Trends and Global Forecasts, till 2035: Distribution by Type of Offering (Instruments / Technologies, Kits and Reagents, and Proteomics Services), Type of Instrument / Technology (Chromatography, Electroph ... Read More
-
mRNA Synthesis and Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product
mRNA Synthesis and Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product The mRNA Synthesis and Manufacturing Market is valued at USD 1.06 billion in 2024. Ribonucleic acid (RNA) is a ubiquitous molecule found in all the living cells, w ... Read More
-
Cell Therapy Packaging Market, Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Therapy Packed
Cell Therapy Packaging Market, Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Therapy Packed The Cell Therapy Packaging Market is valued at USD 361 million in 2024 growing at a CAGR of 11.8% during the forecast period 2024-2035. Cell therapy involves utilizing a patient's ... Read More
-
Oligonucleotide Synthesis Market (3rd Edition): Industry Trends and Global Forecasts, Till 2035 - Application Area
Oligonucleotide Synthesis Market (3rd Edition): Industry Trends and Global Forecasts, Till 2035 - Application Area The Oligonucleotide Synthesis Market is valued at USD 4.8 billion in 2024 growing at a CAGR of 9.9% during the forecast period 2024-2035. Oligonucleotides, commonly referred to as oligo ... Read More
-
CAR T Cell Therapy Market (5th Edition): Industry Trends and Global Forecasts, Till 2035: Distribution by Target Indication
CAR T Cell Therapy Market (5th Edition): Industry Trends and Global Forecasts, Till 2035: Distribution by Target Indication The CAR T Cell Therapy Market is valued at USD 4.6 billion in 2024 growing at a CAGR of 20% during the forecast period 2024-2035 Cancer stands as a leading cause of mortality w ... Read More
Research Assistance
